As of 2024-10-04, the Fair Value of Coherus BioSciences Inc (CHRS) is -1.27 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.04 USD, the upside of Coherus BioSciences Inc is -222.26%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
Historical Earnings | ||||||
2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
Net income | 89.80 | 132.20 | -287.10 | -291.80 | -237.89 | -118.96 |
YoY growth | 142.90% | 47.22% | -317.17% | -1.64% | 18.47% | -22.04% |
Market Cap (mil) | 119.82 |
P/E | |
Forward P/E |
EPS | -0.25 |
Avg earnings growth rate | -22.04% |
TTM earnings | -29.30 |